Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

In primary prevention without previous disease, aspirin is of uncertain net value as the reduction in occlusive events needs to be weighed against any increase in major bleeds. Further trials are in progress.

Related Articles

Efficacy of aspirin for secondary prevention in patients with peripheral artery disease
Expert Review of Cardiovascular Therapy, 10/16/09    Relevance Score: 93%

Efficacy of different doses of aspirin in decreasing blood levels of inflammatory markers in patients with cardiovascular metabolic syndrome
Journal of Pharmacy and Pharmacology, 11/04/09    Relevance Score: 91%

Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy, 10/20/09    Relevance Score: 91%

Comparison of Bleeding Complications With Omega-3 Fatty Acids + Aspirin + Clopidogrel—Versus—Aspirin + Clopidogrel in Patients With Cardiovascular Disease
The American Journal of Cardiology, 10/13/09    Relevance Score: 91%

Time-Dependent Effects of Low-Dose Aspirin on Plasma Renin Activity, Aldosterone, Cortisol, and Catecholamines
Hypertension, 10/12/09    Relevance Score: 89%

Today in Over The Counter (OTC)...keeping you current

Role of free radicals in liver diseases
Hepatology International, 12/02/09

Continuation of Low-Dose Aspirin in Peptic Ulcer Bleeding. A Randomized Trial
Annals of Internal Medicine, 12/01/09

Two cases of wheat-dependent anaphylaxis induced by aspirin administration but not by exercise
Clinical and Experimental Dermatology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address